S&P 500   2,474.23 (-2.08%)
DOW   20,948.13 (-2.17%)
QQQ   182.13 (-2.09%)
AAPL   239.70 (-2.14%)
FB   152.17 (-3.81%)
MSFT   153.33 (-1.24%)
GOOGL   1,078.37 (-3.27%)
AMZN   1,895.17 (-1.23%)
CGC   13.06 (-5.36%)
NVDA   241.41 (-5.50%)
BABA   186.08 (-1.39%)
MU   41.03 (-0.15%)
GE   6.70 (-2.90%)
TSLA   478.05 (+5.19%)
AMD   42.38 (-4.74%)
T   27.34 (-4.97%)
ACB   0.80 (-3.62%)
F   4.26 (-2.29%)
NFLX   359.94 (-2.61%)
BAC   19.88 (-3.40%)
GILD   78.11 (+1.45%)
DIS   93.26 (-3.83%)
S&P 500   2,474.23 (-2.08%)
DOW   20,948.13 (-2.17%)
QQQ   182.13 (-2.09%)
AAPL   239.70 (-2.14%)
FB   152.17 (-3.81%)
MSFT   153.33 (-1.24%)
GOOGL   1,078.37 (-3.27%)
AMZN   1,895.17 (-1.23%)
CGC   13.06 (-5.36%)
NVDA   241.41 (-5.50%)
BABA   186.08 (-1.39%)
MU   41.03 (-0.15%)
GE   6.70 (-2.90%)
TSLA   478.05 (+5.19%)
AMD   42.38 (-4.74%)
T   27.34 (-4.97%)
ACB   0.80 (-3.62%)
F   4.26 (-2.29%)
NFLX   359.94 (-2.61%)
BAC   19.88 (-3.40%)
GILD   78.11 (+1.45%)
DIS   93.26 (-3.83%)
S&P 500   2,474.23 (-2.08%)
DOW   20,948.13 (-2.17%)
QQQ   182.13 (-2.09%)
AAPL   239.70 (-2.14%)
FB   152.17 (-3.81%)
MSFT   153.33 (-1.24%)
GOOGL   1,078.37 (-3.27%)
AMZN   1,895.17 (-1.23%)
CGC   13.06 (-5.36%)
NVDA   241.41 (-5.50%)
BABA   186.08 (-1.39%)
MU   41.03 (-0.15%)
GE   6.70 (-2.90%)
TSLA   478.05 (+5.19%)
AMD   42.38 (-4.74%)
T   27.34 (-4.97%)
ACB   0.80 (-3.62%)
F   4.26 (-2.29%)
NFLX   359.94 (-2.61%)
BAC   19.88 (-3.40%)
GILD   78.11 (+1.45%)
DIS   93.26 (-3.83%)
S&P 500   2,474.23 (-2.08%)
DOW   20,948.13 (-2.17%)
QQQ   182.13 (-2.09%)
AAPL   239.70 (-2.14%)
FB   152.17 (-3.81%)
MSFT   153.33 (-1.24%)
GOOGL   1,078.37 (-3.27%)
AMZN   1,895.17 (-1.23%)
CGC   13.06 (-5.36%)
NVDA   241.41 (-5.50%)
BABA   186.08 (-1.39%)
MU   41.03 (-0.15%)
GE   6.70 (-2.90%)
TSLA   478.05 (+5.19%)
AMD   42.38 (-4.74%)
T   27.34 (-4.97%)
ACB   0.80 (-3.62%)
F   4.26 (-2.29%)
NFLX   359.94 (-2.61%)
BAC   19.88 (-3.40%)
GILD   78.11 (+1.45%)
DIS   93.26 (-3.83%)
Log in

Revance Therapeutics SEC Filings & 10K Form (NASDAQ:RVNC)

$13.90
+0.24 (+1.76 %)
(As of 04/3/2020 03:44 PM ET)
Today's Range
$13.28
Now: $13.90
$14.04
50-Day Range
$12.46
MA: $20.25
$27.81
52-Week Range
$9.88
Now: $13.90
$27.97
Volume35,973 shs
Average Volume1.03 million shs
Market Capitalization$792.72 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

SEC Filings

Revance Therapeutics (NASDAQ:RVNC) SEC Filings

DateFilerForm TypeView
03/17/2020
7:34 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
3:22 PM
GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
Form SC 13G
02/19/2020
7:25 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4/A
02/19/2020
7:23 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:22 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:21 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:20 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:18 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:17 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2020
4:04 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/05/2020
2:17 PM
FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/03/2020
1:20 PM
Revance Therapeutics (Filer)
Form CT ORDER
01/24/2020
7:22 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:21 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:18 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:16 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
3:38 PM
Revance Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/17/2020
7:12 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
9:33 AM
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/10/2020
7:11 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
7:05 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
2:11 PM
Revance Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/03/2020
5:48 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:46 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:42 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:00 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
6:57 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
6:56 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
7:38 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2019
4:09 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
4:08 PM
Revance Therapeutics (Filer)
Form 424B5
11/12/2019
10:27 AM
ArrowMark Colorado Holdings LLC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
11/04/2019
3:14 PM
Revance Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:11 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
7:23 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
7:17 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
7:22 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
3:09 PM
Bank of New York Mellon Corp (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
08/06/2019
3:16 PM
Revance Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
3:08 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
7:29 PM
Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
7:25 PM
Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2019
7:05 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
8:16 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
8:15 PM
Browne L Daniel (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
8:14 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
7:30 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
6:34 PM
Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
6:19 PM
Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2019
7:11 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
8:45 AM
Revance Therapeutics (Filer)
Form CT ORDER
05/10/2019
8:11 PM
Revance Therapeutics (Issuer)
Vickers Philip J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
8:09 PM
Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
8:05 PM
GARDNER PHYLLIS (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
7:54 PM
Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
7:52 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
7:49 PM
BYRNES ROBERT F (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:08 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
3:26 PM
Revance Therapeutics (Filer)
Form DEF 14A
03/19/2019
8:01 PM
Browne L Daniel (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:58 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
7:34 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
3:04 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
3:10 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
8:33 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
8:31 PM
Browne L Daniel (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
6:53 AM
ArrowMark Colorado Holdings LLC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G
02/13/2019
1:39 PM
Essex Woodlands Health Ventures VIII, L.L.C. (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/12/2019
10:36 AM
NovaQuest Pharma Opportunities Fund III, L.P. (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/12/2019
9:00 AM
Revance Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2019
12:56 PM
Bank of New York Mellon Corp (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/28/2019
2:40 PM
FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/25/2019
8:02 PM
Browne L Daniel (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
8:00 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:54 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:51 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:49 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
4:28 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2019
8:38 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
7:55 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
6:01 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
5:56 AM
Revance Therapeutics (Filer)
Form 424B5
01/15/2019
3:54 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
3:25 PM
Revance Therapeutics (Filer)
Form 424B5
01/04/2019
8:33 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
8:29 AM
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/02/2019
7:05 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
7:02 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
8:23 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
7:14 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2018
5:30 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
5:17 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
7:59 PM
Allouche Cyril (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
7:31 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
7:30 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2018
3:10 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
5:53 PM
Revance Therapeutics (Issuer)
Zavodnick Todd Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
7:53 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
3:00 PM
Revance Therapeutics (Filer)
Form CT ORDER
This page was last updated on 4/3/2020 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel